Cyclosporine as preferred calcineurin inhibitor in renal allograft recipients with COVID-19 infection

Kidney International recently published two series of renal allograft recipients with COVID-19 infection including different approaches to maintenance immunosuppression. While Alberici et al.1 report withdrawal of baseline immunosuppression in 20 patients with COVID-19 pneumonia and mainly continuation with methylprednisolone, Banerjee et al.2 pursued more gentle reduction of immunosuppression with mainly discontinuation of the antimetabolite in 7 patients with COVID-19 infection of varying severity.
Source: Kidney International - Category: Urology & Nephrology Authors: Tags: letters to the editor Source Type: research